Correlation Between Oncologix Tech and China Health

Can any of the company-specific risk be diversified away by investing in both Oncologix Tech and China Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncologix Tech and China Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncologix Tech and China Health Management, you can compare the effects of market volatilities on Oncologix Tech and China Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncologix Tech with a short position of China Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncologix Tech and China Health.

Diversification Opportunities for Oncologix Tech and China Health

0.0

Correlation Coefficient

Oncologix Tech  China Health

Pay attention - limited upside

The 3 months correlation between Oncologix and China is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncologix Tech and China Health Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Health Management and Oncologix Tech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncologix Tech are associated (or correlated) with China Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Health Management has no effect on the direction of Oncologix Tech i.e., Oncologix Tech and China Health go up and down completely randomly.

Pair Corralation between Oncologix Tech and China Health

Given the investment horizon of 90 days Oncologix Tech is expected to generate 1.81 times less return on investment than China Health. But when comparing it to its historical volatility, Oncologix Tech is 1.07 times less risky than China Health. It trades about 0.03 of its potential returns per unit of risk. China Health Management is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1.79  in China Health Management on September 17, 2024 and sell it today you would lose (1.39) from holding China Health Management or give up 77.65% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Oncologix Tech  vs.  China Health Management

Oncologix Tech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncologix Tech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Oncologix Tech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

China Health Management

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days China Health Management has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Oncologix Tech and China Health

The main advantage of trading using opposite Oncologix Tech and China Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncologix Tech position performs unexpectedly, China Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Health will offset losses from the drop in China Health's long position.

The idea behind Oncologix Tech and China Health Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.